CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Takeda Pharmaceutical Company Limited - 4502 CFD

4231.25
0.28%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
Trading сonditions
Spread 23.70
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011247 %
Charges from full value of position ($-2.14)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011247%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010976 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010976%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 4219.38
Open 4231.35
1-Year Change -3.01%
Day's Range 4226.17 - 4247.51
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 26, 2024 4241.92 20.84 0.49% 4221.08 4251.20 4212.39
Jul 25, 2024 4227.46 30.03 0.72% 4197.43 4237.04 4181.48
Jul 24, 2024 4232.14 -22.14 -0.52% 4254.28 4265.16 4223.37
Jul 23, 2024 4279.82 41.50 0.98% 4238.32 4284.02 4222.36
Jul 22, 2024 4252.99 16.56 0.39% 4236.43 4253.19 4216.48
Jul 19, 2024 4209.11 -27.92 -0.66% 4237.03 4238.03 4184.57
Jul 18, 2024 4269.85 -0.49 -0.01% 4270.34 4305.96 4265.35
Jul 17, 2024 4291.79 54.75 1.29% 4237.04 4294.39 4237.03
Jul 16, 2024 4209.99 -20.46 -0.48% 4230.45 4239.13 4205.51
Jul 12, 2024 4274.93 -8.98 -0.21% 4283.91 4331.79 4264.36
Jul 11, 2024 4298.78 36.81 0.86% 4261.97 4305.26 4261.97
Jul 10, 2024 4234.04 7.58 0.18% 4226.46 4243.41 4213.49
Jul 9, 2024 4224.07 36.52 0.87% 4187.55 4240.03 4182.56
Jul 8, 2024 4213.69 -14.37 -0.34% 4228.06 4242.02 4211.49
Jul 5, 2024 4227.46 -5.59 -0.13% 4233.05 4252.39 4213.59
Jul 4, 2024 4233.05 -3.29 -0.08% 4236.34 4240.03 4207.61
Jul 3, 2024 4220.08 1.40 0.03% 4218.68 4228.05 4187.65
Jul 2, 2024 4202.12 15.95 0.38% 4186.17 4210.30 4169.70
Jul 1, 2024 4181.28 13.58 0.33% 4167.70 4193.35 4162.72
Jun 28, 2024 4154.25 -11.17 -0.27% 4165.42 4183.38 4147.77

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Takeda Pharmaceutical Company Limited Company profile

About Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Takeda Pharmaceutical Co Ltd revenues increased 11% to Y2.696T. Net income applicable to common stockholders increased 35% to Y241.42B. Revenues reflect Intellectual Property And Service Revenue segment increase from Y69.04B to Y210.55B, Pharmaceutical Business segment increase of 5% to Y2.485T, Northern America segment increase of 9% to Y1.297T, Japan segment increase of 22% to Y530.25B.

Equity composition

FY'94-02 WAS were estimated. FY'04 Name changed from Takeda Chemical Industries, Ltd. to Takeda Pharmaceutical Company Limited. All 1&3Q, WAS were estimated and used as O/S. FY'08 Q3 WAS=O/S. FY'11 Q3 DWAS is estimated.

Industry: Pharmaceuticals (NEC)

4階
日本橋本町二丁目1番1号
CHUO-KU
TOKYO-TO 103-8668
JP

People also watch

BTC/USD

68,006.70 Price
+4.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,387.21 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.60

ETH/USD

3,280.77 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading